Substituted dihydroindene-4-carboxamides and analogs thereof, and methods using same

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 11098010
SERIAL NO

16495794

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention includes novel substituted bicyclic compounds, and compositions comprising the same, that can be used to treat or prevent hepatitis B virus (HBV) infections in a patient. In certain embodiments, the compounds and compositions of the invention are capsid inhibitors.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
ARBUTUS BIOPHARMA CORPORATIONBURNABY BC V5J 5J8

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Cole, Andrew G Cranbury, US 32 167
Dorsey, Bruce D Ambler, US 67 649
Kakarla, Ramesh Doylestown, US 25 217
Kultgen, Steven Hamilton, US 4 0
Quintero, Jorge Sayreville, US 8 88

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
3.5 Year Payment $1600.00 $800.00 $400.00 Feb 24, 2025
7.5 Year Payment $3600.00 $1800.00 $900.00 Feb 24, 2029
11.5 Year Payment $7400.00 $3700.00 $1850.00 Feb 24, 2033
Fee Large entity fee small entity fee micro entity fee
Surcharge - 3.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00